Provided by Tiger Trade Technology Pte. Ltd.

Genmab A/S

36.05
-0.6000-1.64%
Post-market: 36.04-0.0100-0.03%19:30 EDT
Volume:4.30M
Turnover:153.51M
Market Cap:22.17B
PE:28.50
High:36.29
Open:36.18
Low:35.09
Close:36.65
52wk High:40.17
52wk Low:23.62
Shares:615.00M
Float Shares:576.00M
Volume Ratio:0.61
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.54
ROE:14.00%
ROA:8.79%
PB:3.72
PE(LYR):23.45

Loading ...

Genmab : TD Cowen Raises to Buy from Hold; Raises Target Price to $43 from $32

THOMSON REUTERS
·
Jul 22

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jul 21

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Jul 18

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 16

Genmab's Darzalex Generates $4.21 Billion in Q2 Net Trade Sales

MT Newswires Live
·
Jul 15

Analysts Are Bullish on Top Healthcare Stocks: Chemomab Therapeutics (CMMB), Genmab (GMAB)

TIPRANKS
·
Jul 15

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Jul 14

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Krystal Biotech (KRYS) and Denali Therapeutics (DNLI)

TIPRANKS
·
Jul 13

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Jul 11

Genmab A/S Stock Falls Wednesday, Outperforms Market

Dow Jones
·
Jul 09

Exchange-Traded Funds Lower, Equity Futures Mixed Amid Caution Over Chip Sector Outlook

MT Newswires Live
·
Jul 07

Genmab Secures EU Approval for Drug Combination Intended for Relapsed or Refractory Follicular Lymphoma

MT Newswires Live
·
Jul 07

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jul 07

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Jul 04

Genmab is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 02

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 02

Abbvie, Genmab Blood-cancer Drug Has Competitive Profile

Dow Jones
·
Jun 30

Investors See European Pharma Stocks as Funding Source for AI Trades

Dow Jones
·
Jun 30

Guggenheim Reaffirms Their Buy Rating on Genmab (GMAB)

TIPRANKS
·
Jun 30

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB) and Hinge Health, Inc. Class A (HNGE)

TIPRANKS
·
Jun 30